AMCR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Amcor PLC is not a strong buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock has some positive fundamentals and supportive sentiment, but the technical trend is still weak and the current setup does not offer a clean high-conviction entry. If the investor is impatient and wants to act now, I would still choose hold rather than buy, because the upside case is not strong enough to justify an immediate long-term purchase at this price.
AMCR closed at 38.25, up 1.85% on the day and outperforming the broader market move. However, the trend structure remains bearish: MACD histogram is negative and expanding, and the moving averages are aligned bearishly with SMA_200 > SMA_20 > SMA_5. RSI_6 at 32.83 is near oversold but not yet a clear reversal signal. Price is trading just above S1 support at 37.77 and below the pivot at 39.79, which suggests the stock is still in a weak short-term trend despite the bounce. Resistance sits at 41.81 and 43.05, so the stock needs more momentum before confirming a stronger upside trend.
["Amcor opened a new healthcare packaging coating facility in Malaysia, which supports capacity expansion and regional supply-chain reliability.", "Latest quarter financials show strong revenue growth of 68.13% YoY and EPS growth of 239.29% YoY, indicating improving operating scale.", "Congress trading data is constructive: 2 purchase transactions and 0 sales in the last 90 days, suggesting positive institutional-political interest.", "Analyst firms generally still rate the stock Buy/Outperform despite recent target cuts.", "The company is preparing for QMAR 2026 earnings on 2026-05-06, which could provide a fresh catalyst if results are solid."]
["Short-term technical trend is bearish, with MACD deteriorating and moving averages aligned negatively.", "Gross margin declined to 16.43%, down 14.96% YoY, showing profitability pressure even with revenue growth.", "Several analysts lowered price targets recently, signaling more cautious expectations.", "Hedge funds and insiders are both neutral with no strong recent buying trend.", "Similar-pattern trend data suggests only a modest short-term gain probability and a negative one-month expectation."]
In Q2 2026, Amcor delivered strong top-line growth with revenue of $5.449B, up 68.13% YoY. Net income rose 8.59% YoY to $177M, and EPS increased sharply to 1.9, up 239.29% YoY. The main weakness is margin pressure: gross margin fell to 16.43%, down 14.96% YoY. So the latest quarter shows strong growth, but profitability quality is mixed because margins are under pressure.
Recent analyst action remains generally positive but more cautious on valuation expectations. Truist cut its target to $50 from $60 and kept Buy; BofA cut to $48 from $56 and kept Buy; Deutsche Bank initiated Buy with a $50 target; Wells Fargo downgraded to Equal Weight with a $43 target; Citi and Baird previously raised targets to $54, and BofA had earlier lifted to $56. Wall Street pros still lean bullish overall, but the trend in targets has softened, suggesting upside expectations are being trimmed.
